Fig. 2From: Definitive concurrent chemoradiotherapy with docetaxel plus cisplatin versus 5-fluorouracil plus cisplatin in patients with esophageal squamous cell carcinoma: long-term follow-up results of a phase II randomized controlled trialTrial profileDP: docetaxel plus cisplatin; PF: cisplatin plus 5-FUBack to article page